440 related articles for article (PubMed ID: 35433700)
1. Perlecan, A Multi-Functional, Cell-Instructive, Matrix-Stabilizing Proteoglycan With Roles in Tissue Development Has Relevance to Connective Tissue Repair and Regeneration.
Hayes AJ; Farrugia BL; Biose IJ; Bix GJ; Melrose J
Front Cell Dev Biol; 2022; 10():856261. PubMed ID: 35433700
[TBL] [Abstract][Full Text] [Related]
2. Perlecan, a modular instructive proteoglycan with diverse functional properties.
Melrose J
Int J Biochem Cell Biol; 2020 Nov; 128():105849. PubMed ID: 32947020
[TBL] [Abstract][Full Text] [Related]
3. Pentosan Polysulfate, a Semisynthetic Heparinoid Disease-Modifying Osteoarthritic Drug with Roles in Intervertebral Disc Repair Biology Emulating the Stem Cell Instructive and Tissue Reparative Properties of Heparan Sulfate.
Smith MM; Hayes AJ; Melrose J
Stem Cells Dev; 2022 Aug; 31(15-16):406-430. PubMed ID: 35102748
[TBL] [Abstract][Full Text] [Related]
4. Perlecan in Pericellular Mechanosensory Cell-Matrix Communication, Extracellular Matrix Stabilisation and Mechanoregulation of Load-Bearing Connective Tissues.
Guilak F; Hayes AJ; Melrose J
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800241
[TBL] [Abstract][Full Text] [Related]
5. Regulation of FGF-2, FGF-18 and Transcription Factor Activity by Perlecan in the Maturational Development of Transitional Rudiment and Growth Plate Cartilages and in the Maintenance of Permanent Cartilage Homeostasis.
Hayes AJ; Whitelock J; Melrose J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216048
[TBL] [Abstract][Full Text] [Related]
6. Perlecan, the "jack of all trades" proteoglycan of cartilaginous weight-bearing connective tissues.
Melrose J; Hayes AJ; Whitelock JM; Little CB
Bioessays; 2008 May; 30(5):457-69. PubMed ID: 18404701
[TBL] [Abstract][Full Text] [Related]
7. Perlecan/HSPG2: Signaling role of domain IV in chondrocyte clustering with implications for Schwartz-Jampel Syndrome.
Martinez JR; Grindel BJ; Hubka KM; Dodge GR; Farach-Carson MC
J Cell Biochem; 2019 Feb; 120(2):2138-2150. PubMed ID: 30203597
[TBL] [Abstract][Full Text] [Related]
8. Perlecan domain I gradients establish stable biomimetic heparin binding growth factor gradients for cell migration in hydrogels.
Hubka KM; Carson DD; Harrington DA; Farach-Carson MC
Acta Biomater; 2019 Oct; 97():385-398. PubMed ID: 31351252
[TBL] [Abstract][Full Text] [Related]
9. Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.
Ishijima M; Suzuki N; Hozumi K; Matsunobu T; Kosaki K; Kaneko H; Hassell JR; Arikawa-Hirasawa E; Yamada Y
Matrix Biol; 2012 May; 31(4):234-45. PubMed ID: 22421594
[TBL] [Abstract][Full Text] [Related]
10. Altered stress induced by partial transection of the infraspinatus tendon leads to perlecan (HSPG2) accumulation in an ovine model of tendinopathy.
Melrose J; Smith MM; Smith SM; Ravi V; Young AA; Dart AJ; Sonnabend DH; Little CB
Tissue Cell; 2013 Feb; 45(1):77-82. PubMed ID: 23245384
[TBL] [Abstract][Full Text] [Related]
11. A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation.
Farach-Carson MC; Brown AJ; Lynam M; Safran JB; Carson DD
Matrix Biol; 2008 Mar; 27(2):150-60. PubMed ID: 17997086
[TBL] [Abstract][Full Text] [Related]
12. Perlecan: a review of its role in neurologic and musculoskeletal disease.
Lavorgna TR; Gressett TE; Chastain WH; Bix GJ
Front Physiol; 2023; 14():1189731. PubMed ID: 37324385
[TBL] [Abstract][Full Text] [Related]
13. Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.
Farach-Carson MC; Warren CR; Harrington DA; Carson DD
Matrix Biol; 2014 Feb; 34():64-79. PubMed ID: 24001398
[TBL] [Abstract][Full Text] [Related]
14. Perlecan domain IV peptide stimulates salivary gland cell assembly in vitro.
Pradhan S; Zhang C; Jia X; Carson DD; Witt R; Farach-Carson MC
Tissue Eng Part A; 2009 Nov; 15(11):3309-20. PubMed ID: 19382872
[TBL] [Abstract][Full Text] [Related]
15. Perlecan in the Natural and Cell Therapy Repair of Human Adult Articular Cartilage: Can Modifications in This Proteoglycan Be a Novel Therapeutic Approach?
Garcia J; McCarthy HS; Kuiper JH; Melrose J; Roberts S
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33450893
[TBL] [Abstract][Full Text] [Related]
16. Type XI collagen-perlecan-HS interactions stabilise the pericellular matrix of annulus fibrosus cells and chondrocytes providing matrix stabilisation and homeostasis.
Smith SM; Melrose J
J Mol Histol; 2019 Jun; 50(3):285-294. PubMed ID: 30993430
[TBL] [Abstract][Full Text] [Related]
17. Perlecan displays variable spatial and temporal immunolocalisation patterns in the articular and growth plate cartilages of the ovine stifle joint.
Melrose J; Smith S; Cake M; Read R; Whitelock J
Histochem Cell Biol; 2005 Jun; 123(6):561-71. PubMed ID: 16021525
[TBL] [Abstract][Full Text] [Related]
18. Elevated hypertrophy, growth plate maturation, glycosaminoglycan deposition, and exostosis formation in the
Shu CC; Smith SM; Little CB; Melrose J
Biochem J; 2019 Jan; 476(2):225-243. PubMed ID: 30563944
[TBL] [Abstract][Full Text] [Related]
19. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis.
Shu CC; Jackson MT; Smith MM; Smith SM; Penm S; Lord MS; Whitelock JM; Little CB; Melrose J
Arthritis Rheumatol; 2016 Apr; 68(4):868-79. PubMed ID: 26636652
[TBL] [Abstract][Full Text] [Related]
20. Achilles and tail tendons of perlecan exon 3 null heparan sulphate deficient mice display surprising improvement in tendon tensile properties and altered collagen fibril organisation compared to C57BL/6 wild type mice.
Shu CC; Smith MM; Appleyard RC; Little CB; Melrose J
PeerJ; 2018; 6():e5120. PubMed ID: 30042881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
